LongView Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

LongView Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Sell	471 -5	-1%	-$2.4K	0.06%	212
2026 Q1	$251K	Buy	476 +1	+0.2%	+$543	0.06%	217
2025 Q4	$292K	Sell	475 -2	-0.4%	-$1.13K	0.07%	206
2025 Q3	$231K	Buy	+477	New	+$222K	0.06%	212
2025 Q2	–	Sell	-476	Closed	-$237K	–	221
2025 Q1	$237K	Sell	476 -29	-6%	-$15.7K	0.07%	185
2024 Q4	$263K	Sell	505 -7	-1%	-$3.85K	0.08%	174
2024 Q3	$317K	Sell	512 -5	-1%	-$2.96K	0.1%	160
2024 Q2	$286K	Sell	517 -34	-6%	-$19.5K	0.11%	152
2024 Q1	$320K	Sell	551 -7	-1%	-$3.93K	0.13%	138
2023 Q4	$303K	Buy	+558	New	+$270K	0.14%	137

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

LongView Wealth Management's TMO Position: Q2 2026 in Review

LongView Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $2.4K and leaving 471 shares worth $236K. The position accounts for 0.06% of the portfolio, ranked #212.

LongView Wealth Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $320K in Q1 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

LongView Wealth Management held 471 shares of Thermo Fisher Scientific worth $236K as of Q2 2026.
LongView Wealth Management sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
Thermo Fisher Scientific made up 0.06% of LongView Wealth Management's portfolio in Q2 2026, its #212 holding.
LongView Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
LongView Wealth Management's Thermo Fisher Scientific position peaked at $320K in Q1 2024.
794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LongView Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.